Author: Peter Mansell

Efforts to give medical researchers in Ireland more of a say in policy-making both at the national and European level saw the formal launch last week of a new Academy of Medical Sciences at Dublin’s Royal College of Surgeons in Dublin.

The UK’s SkyePharma has managed to salvage some jobs threatened by cost-cutting at its R&D facility in Muttenz, Switzerland by consolidating its relationship with Aenova, the German group whose French subsidiary leased SkyePharma’s manufacturing business at Saint Quentin-Fallavier, Lyon in August 2011.

Phase III clinical studies for multi-drug resistant HIV need to evolve from traditional superiority or non-inferiority designs to a new approach in which clinical improvements are demonstrated through short, step-wise efficacy and safety trials, argues a US-based stakeholder group.

Parexel International has further expanded its global clinical logistics infrastructure with a new ancillary warehouse in the greater Boston area of the US and a “significantly enlarged” depot in Santiago, Chile.

Boehringer Ingelheim (BI) has teamed up with a university and a knowledge/technology transfer specialist in its home country of Germany to explore the causes of diabetes.